154 related articles for article (PubMed ID: 4007029)
1. The acute changes in serum binding of disopyramide and flecainide after myocardial infarction.
Caplin JL; Johnston A; Hamer J; Camm AJ
Eur J Clin Pharmacol; 1985; 28(3):253-5. PubMed ID: 4007029
[TBL] [Abstract][Full Text] [Related]
2. Prolonged variability in plasma protein binding of disopyramide after acute myocardial infarction.
David BM; Ilett KF; Whitford EG; Stenhouse NS
Br J Clin Pharmacol; 1983 Apr; 15(4):435-41. PubMed ID: 6849779
[TBL] [Abstract][Full Text] [Related]
3. Binding of alfentanil to human alpha 1-acid glycoprotein, albumin and serum.
Belpaire FM; Bogaert MG
Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):96-102. PubMed ID: 2071261
[TBL] [Abstract][Full Text] [Related]
4. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes.
Kjekshus J; Bathen J; Orning OM; Storstein L
Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140
[TBL] [Abstract][Full Text] [Related]
6. Relationship between alpha 1-acid glycoprotein and distribution of disopyramide and mono-N-dealkyldisopyramide in whole blood.
Bredesen JE; Kierulf P
Br J Clin Pharmacol; 1986 Sep; 22(3):281-6. PubMed ID: 3768240
[TBL] [Abstract][Full Text] [Related]
7. Differences between blacks and whites in plasma protein binding of drugs.
Johnson JA; Livingston TN
Eur J Clin Pharmacol; 1997; 51(6):485-8. PubMed ID: 9112064
[TBL] [Abstract][Full Text] [Related]
8. Protein binding of disopyramide and elevated alpha-1-acid glycoprotein concentrations in serum obtained from dialysis patients and renal transplant recipients.
Haughey DB; Kraft CJ; Matzke GR; Keane WF; Halstenson CE
Am J Nephrol; 1985; 5(1):35-9. PubMed ID: 3881959
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of disopyramide.
Siddoway LA; Woosley RL
Clin Pharmacokinet; 1986; 11(3):214-22. PubMed ID: 3524956
[TBL] [Abstract][Full Text] [Related]
10. Alpha-1-acid glycoprotein concentration and the protein binding of disopyramide in healthy subjects.
Kishino S; Nomura A; Di ZS; Sugawara M; Iseki K; Kakinoki S; Kitabatake A; Miyazaki K
J Clin Pharmacol; 1995 May; 35(5):510-4. PubMed ID: 7657852
[TBL] [Abstract][Full Text] [Related]
11. Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide.
Bredesen JE; Kierulf P
Br J Clin Pharmacol; 1984 Nov; 18(5):779-84. PubMed ID: 6508986
[TBL] [Abstract][Full Text] [Related]
12. Changes in the binding capacity of alpha-1-acid glycoprotein in patients with renal insufficiency.
Kishino S; Nomura A; Di ZS; Sugawara M; Iseki K; Kakinoki S; Kitabatake A; Miyazaki K
Ther Drug Monit; 1995 Oct; 17(5):449-53. PubMed ID: 8585106
[TBL] [Abstract][Full Text] [Related]
13. Influence of age and gender on the in vitro serum protein binding of flecainide.
Zordan R; Padrini R; Bernini V; Piovan D; Ferrari M
Pharmacol Res; 1993; 28(3):259-64. PubMed ID: 8108316
[TBL] [Abstract][Full Text] [Related]
14. Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics.
Lima JJ; Boudoulas H; Blanford M
J Pharmacol Exp Ther; 1981 Dec; 219(3):741-7. PubMed ID: 7299695
[TBL] [Abstract][Full Text] [Related]
15. Dynamic variability of binding of antiarrhythmic drugs during the evolution of acute myocardial infarction.
Kessler KM; Kissane B; Cassidy J; Pefkaros KC; Kozlovskis P; Hamburg C; Myerburg RJ
Circulation; 1984 Sep; 70(3):472-8. PubMed ID: 6744551
[TBL] [Abstract][Full Text] [Related]
16. Age- and gender-related differences in carbohydrate concentrations of alpha1-acid glycoprotein variants and the effects of glycoforms on their drug-binding capacities.
Kishino S; Nomura A; Itoh S; Nakagawa T; Takekuma Y; Sugawara M; Furukawa H; Todo S; Miyazaki K
Eur J Clin Pharmacol; 2002 Dec; 58(9):621-8. PubMed ID: 12483455
[TBL] [Abstract][Full Text] [Related]
17. [A comparison of alpha 1-acid glycoprotein (AAG) concentration and disopyramide binding in Chinese and Japanese].
Jin EZ
Hokkaido Igaku Zasshi; 1999 Jul; 74(4):279-88. PubMed ID: 10480035
[TBL] [Abstract][Full Text] [Related]
18. Nomogram for estimating plasma unbound disopyramide concentrations in patients with varying plasma alpha 1-acid glycoprotein concentrations.
Echizen H; Ishikawa S; Koike K; Ishizaki T
Ther Drug Monit; 1995 Apr; 17(2):145-52. PubMed ID: 7624903
[TBL] [Abstract][Full Text] [Related]
19. Comparative haemodynamic effects of intravenous lignocaine, disopyramide and flecainide in uncomplicated acute myocardial infarction.
Silke B; Frais MA; Verma SP; Reynolds GW; Hafizullah M; Kalra PA; Jackson NC; Taylor SH
Br J Clin Pharmacol; 1986 Dec; 22(6):707-14. PubMed ID: 3105568
[TBL] [Abstract][Full Text] [Related]
20. Protein binding of disopyramide--displacement by mono-N-dealkyldisopyramide and variation with source of alpha-1-acid glycoprotein.
Haughey DB; Steinberg I; Lee MH
J Pharm Pharmacol; 1985 Apr; 37(4):285-8. PubMed ID: 2860235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
